Prediction of gestational diabetes mellitus in the first trimester: comparison of C-reactive protein, fasting plasma glucose, insulin and insulin sensitivity indices
The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To develop a predictive index based on high sensitivity C-reactive protein (hs-CRP), fasting plasma glucose (FPG) and fasting plasma insulin (FPI) measurements for early diagnosis of gestational diabetes mellitus (GDM). METHODS: Healthy pregnant women who were screened for GDM during their first antenatal visit were included in this retrospective cohort study. FPG, FPI and serum hs-CRP concentrations were measured between weeks 11 and 14. A two-step glucose challenge test was carried out between gestational weeks 24 and 28. Fasting glucose/insulin ratio (FIGR), Homeostatic Model Assessment Insulin Resistance (HOMA-IR), HOMA-β indices and Quantitative Insulin Sensitivity Check Index (QUICKI) were used to estimate insulin sensitivity and β-cell function. RESULTS: Of the 450 women who were eligible for the study, 49 (11.2%) were diagnosed with GDM at weeks 24-28. The median FPG and hs-CRP levels were higher in the GDM diagnosed women compared to the others. Comparison of accuracy measures resulted in the highest specificity (87.2%; 95% CI 83.5-90.1) and diagnostic odds ratio (3.9; 95% CI 2.1-7.6) for hs-CRP. CONCLUSION: FPG and hs-CRP in the first trimester are correlated with later development of GDM in the pregnancy. In our study, FPG provided a better sensitivity while hs-CRP exhibited a better specificity for prediction of GDM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Faul, F., Erdfelder, E., Lang, A.-G., & Buchner, A. (2007) · Behavior Research Methods · doi:10.3758/bf03193146 · Cited by 65,971
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
International Association of Diabetes and Pregnancy Study Groups Consensus Panel (2010) · Diabetes Care · doi:10.2337/dc09-1848 · Cited by 5,390 · cited 1×
“The cut-off value for FPG was 90 mg/dL within the normal range but very close to the IADPSG criteria of 92 mg/dL as a GDM diagnosis in the first antenatal visit [38].”
BackgroundStandards of medical care in diabetes—2013
American Diabetes Association (2013) · Diabetes Care · doi:10.2337/dc13-s011 · Cited by 4,369
Katz, A., Nambi, S. S., Mather, K., Baron, A. D., Follmann, D. A., Sullivan, G., & Quon, M. J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6661 · Cited by 3,931 · cited 1×
“insulin mU/L) + log(fasting glucose mg/dL)) [13].”
Effect of Treatment of Gestational Diabetes Mellitus on Pregnancy Outcomes
Crowther, C. A., Hiller, J. E., Moss, J. R., McPhee, A. J., Jeffries, W. S., & Robinson, J. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042973 · Cited by 3,159
A Multicenter, Randomized Trial of Treatment for Mild Gestational Diabetes
Landon, M. B., Spong, C. Y., Thom, E., Carpenter, M. W., Ramin, S. M., Casey, B., Wapner, R. J., Varner, M. W., Rouse, D. J., Thorp, J. M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0902430 · Cited by 2,122 · cited 1×
“treatment of mild gestational diabetes (MFMUN-GDM) study [4,5].”
Criteria for screening tests for gestational diabetes
Carpenter, M. W., & Coustan, D. R. (1982) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(82)90349-0 · Cited by 1,924 · cited 1×
“criteria (0-h 95 mg/dL, 1-h 180 mg/dL, 2-h 155 mg/dL, 3-h 140 mg/dL) [12].”
Metzger, B. E., Gabbe, S. G., Persson, B., Lowe, L. P., Dyer, A. R., Oats, J. J. N., & Buchanan, T. A. (2010) · Diabetes Care · doi:10.2337/dc10-0719 · Cited by 1,888
Cited by
Inflammation in maternal obesity and gestational diabetes mellitus
Pantham, P., Aye, I. L. M. H., & Powell, T. L. (2015) · Placenta · doi:10.1016/j.placenta.2015.04.006 · Cited by 582
Du, Y., Rafferty, A. R., McAuliffe, F. M., Wei, L., & Mooney, C. (2022) · Scientific Reports · doi:10.1038/s41598-022-05112-2 · Cited by 128
“Our models included a very small set of features (4 or 5) compared with published models (4-2355), which means our models would be easier and faster to use.”
MethodHabibi, N., Mousa, A., Tay, C. T., Khomami, M. B., Patten, R. K., Andraweera, P. H., Wassie, M., Vandersluys, J., Aflatounian, A., Bianco‐Miotto, T., et al. (2022) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3532 · Cited by 53
“Nine studies comprising eight unique samples were included in the meta‐analysis.(53,60,62,72,73,97,104,105) Increased FPG in early pregnancy was associated with a higher odds for GDM (unadjusted OR 2.”
BackgroundEarly Gestational Diabetes Mellitus: Diagnostic Strategies and Clinical Implications
Bhattacharya, S., Nagendra, L., Krishnamurthy, A., Lakhani, O. J., Kapoor, N., Kalra, B., & Kalra, S. (2021) · Medical Sciences · doi:10.3390/medsci9040059 · Cited by 43
Evaluation of serum zonulin for use as an early predictor for gestational diabetes
Mokkala, K., Tertti, K., Rönnemaa, T., Vahlberg, T., & Laitinen, K. (2017) · Nutrition & Diabetes · doi:10.1038/nutd.2017.9 · Cited by 41
Corcoran, S. M., Achamallah, N., Loughlin, J. O., Stafford, P., Dicker, P., Malone, F. D., & Breathnach, F. (2018) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2017.12.051 · Cited by 40
Wei, Y.-M., Liu, X.-Y., Shou, C., Liu, X.-H., Meng, W.-Y., Wang, Z.-L., Wang, Y.-F., Wang, Y.-Q., Cai, Z.-Y., Shang, L.-X., et al. (2019) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000158 · Cited by 22
Metadata
- Authors
- Ozgu-Erdinc, A. S., Yilmaz, S., Yeral, M. I., Seckin, K. D., Erkaya, S., & Danisman, A. N.
- Venue
- The Journal of Maternal-Fetal & Neonatal Medicine
- Publisher
- Informa UK Limited
- Published
- 2014-10-28
- Volume
- 28
- Issue
- 16
- Pages
- 1957-1962
- ISSN
- 1476-4954 (ISSN-L)
- 1476-7058
- OpenAlex
- W2121356069
- Cited by
- 73
- References
- 18
- FWCI
- 5.72
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.